उत्पाद विवरण
Celvestrant 250 mg injection is a targeted anticancer treatment specifically designed for postmenopausal women battling hormone receptor-positive, HER2-negative breast cancer. This innovative medication is particularly effective when used in combination with palbociclib for those with locally advanced or metastatic disease who have previously undergone endocrine therapy. Celvestrant functions by inhibiting estrogen's effects, thereby slowing the proliferation of cancer cells and helping to manage disease progression. It's crucial for patients to be aware of potential side effects, which may include hot flashes, fatigue, or gastrointestinal disturbances, and to discuss these with their healthcare provider. Regular monitoring is essential to ensure the treatment's effectiveness and adjust dosages as necessary. As with any cancer therapy, Celvestrant should only be administered under the guidance of a qualified healthcare professional. With its unique mechanism of action, Celvestrant represents a vital option in the ongoing fight against breast cancer, offering hope and improved outcomes for women in need.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese